Blossom Pulse Archive

What happened in psychedelic research in 1967

2 events from 1967, dated by when they happened rather than when we logged them. Papers as they published, trials starting and finishing, programme milestones, and the news coverage around them, grouped by week.

Browse by year

Week of 25 September 1967

  • This open-label clinical study (n=128) investigated whether LSD (100μg) can alleviate death-anxiety in terminally ill patients by decreasing the anticipation of their illness, and found that the administration of LSD was universally well tolerated. Specific effects included a general lift of mood that lasted for 11-12 hours, acute pain relief that lasted 12 hours, decreased the total pain intensity for 3 weeks, and diminished concern over the anticipation of death for up to 3 days after administration.

    LSDAdolescentsDepressive DisordersAnxiety DisordersChronic PainPalliative & End-of-Life Distress

    View paper

Week of 26 December 1966

  • This unregistered trial (n=128) was an open-label clinical series of single-dose LSD for anticipatory anxiety and pain in pre-terminal cancer patients, which demonstrated a reduction in psychological distress and improved sleep patterns.

    LSD

    View trial

Showing 2 of 2 in 1967